PRENTISS SMITH & CO INC – Regeneron Pharmaceuticals, Inc. Transaction History
PRENTISS SMITH & CO INC portfolio value:
$4.06M
portfolio value
PRENTISS SMITH & CO INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.45% | -148 shares | 489K | $688.87 | 5.89K |
| Q2 2022 | share | Decrease | -2.09% | -129 shares | -738K | $591.13 | 6.04K |
| Q1 2022 | share | Decrease | -47.71% | -5.63K shares | -3.14M | $698.42 | 6.17K |
| Q4 2021 | share | Increase | +2.85% | 327 shares | 509K | $642.51 | 11.81K |
| Q3 2021 | share | Decrease | -0.09% | -10 shares | 530K | $605.18 | 11.48K |
| Q2 2021 | share | Decrease | -2.14% | -251 shares | 862K | $558.54 | 11.49K |
| Q1 2021 | share | Increase | +72.00% | 4.91K shares | 2.25M | $473.14 | 11.74K |
| Q4 2020 | share | Decrease | -11.69% | -904 shares | -1.02M | $483.11 | 6.82K |
| Q3 2020 | share | Decrease | -1.80% | -142 shares | -583K | $559.78 | 7.73K |
| Q2 2020 | share | Increase | +0.08% | 6 shares | 1.06M | $623.65 | 7.87K |
| Q1 2020 | share | Decrease | -51.12% | -8.22K shares | -2.20M | $488.29 | 7.86K |
| Q4 2019 | share | Decrease | -2.40% | -395 shares | 1.46M | $375.48 | 16.09K |
| Q3 2019 | share | Increase | +0.38% | 62 shares | -568K | $277.4 | 16.49K |
| Q2 2019 | share | Increase | 0.00% | 16.43K shares | 5.14M | $313 | 16.43K |
| Q1 2019 | share | Decrease | -100.00% | -6.95K shares | -2.59M | $410.62 | 0 |
| Q4 2018 | share | Increase | +1.12% | 77 shares | -181K | $373.5 | 6.95K |
| Q3 2018 | share | Decrease | -39.53% | -4.49K shares | -1.14M | $404.04 | 6.87K |
| Q2 2018 | share | Decrease | -42.45% | -8.38K shares | -2.88M | $344.99 | 11.36K |
| Q1 2018 | share | Increase | +55.58% | 7.05K shares | 2.02M | $344.36 | 19.75K |
| Q4 2017 | share | Increase | +1263.69% | 11.76K shares | 4.35M | $375.96 | 12.69K |
| Q3 2017 | share | Increase | 0.00% | 931 shares | 416K | $447.12 | 931 |
| Q2 2017 | share | Decrease | -100.00% | -751 shares | -291K | $491.14 | 0 |
| Q1 2017 | share | Increase | +13.79% | 91 shares | 49K | $387.51 | 751 |
| Q4 2016 | share | Increase | +277.14% | 485 shares | 172K | $367.09 | 660 |
| Q3 2016 | share | 0.00% | 0 shares | 9K | $402.02 | 175 | |
| Q2 2016 | share | 0.00% | 0 shares | -2K | $349.23 | 175 | |
| Q1 2016 | share | 0.00% | 0 shares | -32K | $360.44 | 175 |